new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




  

Asuragen Inc patents

Recent patent applications related to Asuragen Inc. Asuragen Inc is listed as an Agent/Assignee. Note: Asuragen Inc may have other listings under different names/spellings. We're not affiliated with Asuragen Inc, we're just tracking patents.

ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "A" | Asuragen Inc-related inventors




Date Asuragen Inc patents (updated weekly) - BOOKMARK this page
02/09/17Methods and compositions involving mirna and mirna inhibitor molecules
12/17/15Methods and compositions involving mirna and mirna inhibitor molecules
12/10/15Methods and compositions involving mirna and mirna inhibitor molecules
12/03/15Methods and compositions involving mirna and mirna inhibitor molecules
12/03/15Methods and compositions involving mirna and mirna inhibitor molecules
10/22/15Methods and compositions involving mirna and mirna inhibitor molecules
10/08/15Methods and compositions involving mirna and mirna inhibitor molecules
10/08/15Methods and compositions involving mirna and mirna inhibitor molecules
10/01/15Methods and compositions involving mirna and mirna inhibitor molecules
01/01/15Methods and compositions involving mirna and mirna inhibitor molecules
01/01/15Methods and compositions involving mirna and mirna inhibitor molecules
11/27/14Methods and compositions involving mirna and mirna inhibitor molecules
11/27/14Methods and compositions involving mirna and mirna inhibitor molecules
11/27/14Methods and compositions involving mirna and mirna inhibitor molecules
09/18/14Mirna biomarkers of lung disease
09/04/14Pcr methods for characterizing the 5' untranslated region of the fmr1 and fmr2 genes
08/21/14Mirna biomarkers of prostate disease
08/14/14Methods and compositions involving microrna
05/22/14Mirnas differentially expressed in lymph nodes from cancer patients
04/10/14Diagnostic mirnas for differential diagnosis of incidental pancreatic cystic lesions
01/30/14Methods and compositions involving mirna and mirna inhibitor molecules
01/23/14Comprehensive fmr1 genotyping
07/18/13Micrornas differentially expressed in cervical cancer and uses thereof
06/20/13Methods and compositions involving mirna expression levels for distinguishing pancreatic cysts
06/06/13Mirnas as diagnostic biomarkers to distinguish benign from malignant thyroid tumors
06/06/13Methods and compositions involving mirna and mirna inhibitor molecules
03/03/11Mirna biomarkers of lung disease
11/25/10Mirna biomarkers of prostate disease
07/30/09Mir-124 regulated genes and pathways as targets for therapeutic intervention
07/23/09Micrornas differentially expressed in cervical cancer and uses thereof
05/21/09Mir-15, mir-26, mir-31, mir-145, mir-147, mir-188, mir-215, mir-216, mir-331, mmu-mir-292-3p regulated genes and pathways as targets for therapeutic intervention
04/09/09Micrornas differentially expressed in leukemia and uses thereof







ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Asuragen Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Asuragen Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';